Background: Acute aortic dissection is known as the most dangerous aortic disease
, with management and prognosis determined as the disruption of the medial layer provoked by intramural bleeding.
2) Stent graft placement is proving to be a safe, minimally invasive and effective treatment for thoracic aortic disease
in poor surgical candidates, and short-term morbidity and mortality rates from endovascular repair compare favourably with those from surgery.
may be congenital or acquired during a patient's lifetime.
The database currently tags 42,000 individuals working in Aortic Diseases
Research has shown that compared with CE-MRA, bSSFP in patients with thoracic aortic diseases
provides equivalent measurements of aortic diameter, comparable sensitivity and specificity, and better visualization of the aortic root.
Describe percutaneous approaches to mitral and aortic diseases
Already a market leader in the treatment of AAAs, the company has recently had two major landmarks with its advanced technologies in the treatment of aortic diseases
The GORE EXCLUDER Device and the GORE TAG Device have already proven to be valuable alternatives to invasive open surgery elsewhere, and Gore welcomes the opportunity to advance less invasive endovascular therapies for aortic diseases
In a move that dramatically expands Cook Medical's already industry-leading portfolio of advanced devices to treat aortic diseases
, company officials announced Cook has received approval from the U.
This is an important clinical milestone not only for the surgical team and the University of Florida but for the worldwide treatment of thoracic and abdominal aortic diseases
," said Phil Nowell, global director of Cook Medical's Aortic Intervention strategic business unit.
With the regulatory clearance of the GORE EXCLUDER device, Gore welcomes the opportunity to help advance endovascular therapy of aortic diseases
in Japan," said John Sininger, Leader of the Medical Products Division at Gore.
NYSE:MDT) today announced the completion of patient enrollment for the VALOR clinical trial, a pivotal study evaluating the safety and efficacy of the Talent(TM) thoracic stent graft system for the treatment of thoracic aortic diseases